Comparison of infrapatellar and subcutaneous adipose tissue stromal vascular fraction and stromal/stem cells in osteoarthritic subjects

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 10, 2014, Pages 757-762

  Pires de Carvalho, Pedro ^a,b   Hamel, Katie M ^a   Duarte, Robert ^c   King, Andrew G S ^c   Haque, Masudul ^d   Dietrich, Marilyn A ^d   Wu, Xiying ^a   Shah, Forum ^a   Burk, David ^a   Reis, Rui L ^b   Rood, Jennifer ^a   Zhang, Ping ^c,e   Lopez, Mandi ^c,d   Gimble, Jeffrey M ^a,c   Dasa, Vinod ^c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF MINHO   (Portugal)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Flow cytometry; Immunophenotype; Infrapatellar fat pad; Obesity; Osteoarthritis; Subcutaneous adipose tissue

Indexed keywords

BONE; CELL CULTURE; FLOW CYTOMETRY; KNEE PROSTHESES; NUTRITION; PHOSPHATASES; REFORESTATION; STEM CELLS; TISSUE REGENERATION;

'CURRENT; ADIPOSE DERIVED STEM CELLS; CELL POPULATIONS; IMMUNE CELLS; IMMUNOPHENOTYPES; INFRAPATELLAR FAT PAD; OSTEOARTHRITIS; STROMAL STEM CELLS; SUBCUTANEOUS ADIPOSE TISSUES; VASCULAR FRACTIONS;

CELL PROLIFERATION;

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; ANTIGEN; BETA1 INTEGRIN; CD14 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD66 ANTIGEN; CD8 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ADULT; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL POPULATION; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTIVE SURGERY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFRAPATELLAR FAT PAD; LIPOSUCTION; OSTEOARTHRITIS; STROMA CELL; STROMAL VASCULAR FRACTION CELL; SUBCUTANEOUS FAT; TOTAL KNEE ARTHROPLASTY; AGED; CLINICAL TRIAL; ENDOTHELIUM CELL; FEMALE; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PLURIPOTENT STEM CELL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ARTHROPLASTY, REPLACEMENT, KNEE; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PLURIPOTENT STEM CELLS; SUBCUTANEOUS FAT;

EID: 84907897425     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1565     Document Type: Article

References (42)

1. Apovian CM, Bigornia S, Mott M, et al. 2008; Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 28(9): 1654-1659.
2. Aust L, Devlin B, Foster SJ, et al. 2004; Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6(1): 7-14.
3. Buckley CT, Vinardell T, Kelly DJ. 2010a; Oxygen tension differentially regulates the functional properties of cartilaginous tissues engineered from infrapatellar fat pad derived MSCs and articular chondrocytes. Osteoarthr Cartilage 18(10): 1345-1354.
4. Buckley CT, Vinardell T, Thorpe SD, et al. 2010b; Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J Biomech 43(5): 920-926.
5. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, et al. 2010; The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthr Cartilage 18(7): 876-882.
6. Dragoo JL, Samimi B, Zhu M, et al. 2003; Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 85(5): 740-747.
7. Duffaut C, Galitzky J, Lafontan M, et al. 2009a; Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 384(4): 482-485.
8. Duffaut C, Zakaroff-Girard A, Bourlier V, et al. 2009b; Interplay between human adipocytes and T lymphocytes in obesity. CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 29(10): 1608-1614.
9. Erickson GR, Gimble JM, Franklin DM, et al. 2002; Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290(2): 763-769.
10. Feuerer M, Herrero L, Cipolletta D, et al. 2009; Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8): 930-939.
11. Gimble JM, Katz AJ, Bunnell BA. 2007; Adipose-derived stem cells for regenerative medicine. Circ Res 100(9): 1249-1260.
12. Gronthos S, Franklin DM, Leddy HA, et al. 2001; Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189(1): 54-63.
13. Guilak F, Lott KE, Awad HA, et al. 2006; Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206(1): 229-237.
14. Halvorsen YD, Franklin D, Bond AL, et al. 2001; Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 7(6): 729-741.
15. Izadpanah R, Trygg C, Patel B, et al. 2006; Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99: 1286-1297.
16. Katz AJ, Tholpady A, Tholpady SS, et al. 2005; Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23(3): 412-423.
17. Kellgren JH, Lawrence JS. 1957; Radiological assessment of osteoarthrosis. Ann Rheum Dis 16(4): 494-502.
18. Khan WS, Adesida AB, Tew SR, et al. 2009; The epitope characterisation and the osteogenic differentiation potential of human fat pad-derived stem cells is maintained with ageing in later life. Injury 40(2): 150-157.
19. Khan WS, Johnson DS, Hardingham TE. 2010; The potential of stem cells in the treatment of knee cartilage defects. Knee 17(6): 369-374.
20. Khan WS, Tew SR, Adesida AB, et al. 2008; Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther 10(4): R74.
21. Kloting N, Fasshauer M, Dietrich A, et al. 2010; Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299(3): E506-E515.
22. Kurtz S, Ong K, Lau E, et al. 2007; Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89(4): 780-785.
23. Liossis SN, Tsokos GC. 1998; Cellular immunity in osteoarthritis: novel concepts for an old disease. Clin Diagn Lab Immunol 5(4): 427-429.
24. Maumus M, Peyrafitte JA, D'Angelo R, et al. 2011; Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) 35(9): 1141-1153.
25. McIntosh K, Zvonic S, Garrett S, et al. 2006; The immunogenicity of human adipose derived cells: temporal changes in vitro. Stem Cells 24: 1245-1253.
26. Mitchell JB, McIntosh K, Zvonic S, et al. 2006; The immunophenotype of human adipose derived cells: temporal changes in stromal- and stem cell-associated markers. Stem Cells 24: 376-385.
27. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8): 914-920.
28. Pasarica M, Gowronska-Kozak B, Burk D, et al. 2009; Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab 94(12): 5155-5162.
29. Saddik D, McNally EG, Richardson M. 2004; MRI of Hoffa's fat pad. Skel Radiol 33(8): 433-444.
30. Sakkas LI, Platsoucas CD. 2007; The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum 56(2): 409-424.
31. Sakkas LI, Scanzello C, Johanson N, et al. 1998; T cells and T cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 5(4): 430-437.
32. Staszkiewicz J, Frazier TP, Rowan BG, et al. 2010; Cell growth characteristics, differentiation frequency, and immunophenotype of adult ear mesenchymal stem cells. Stem Cells Dev 19(1): 83-92.
33. Strissel KJ, Stancheva Z, Miyoshi H, et al. 2007; Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56(12): 2910-2918.
34. Vinardell T, Buckley CT, Thorpe SD, et al. 2011; Composition-function relations of cartilaginous tissues engineered from chondrocytes and mesenchymal stem cells isolated from bone marrow and infrapatellar fat pad. J Tissue Eng Regen Med 5(9): 673-683.
35. Weisberg SP, McCann D, Desai M, et al. 2003; Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12): 1796-1808.
36. Wickham MQ, Erickson GR, Gimble JM, et al. 2003; Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 412: 196-212.
37. Winer S, Chan Y, Paltser G, et al. 2009; Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15(8): 921-929.
38. Xu H, Barnes GT, Yang Q, et al. 2003; Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12): 1821-1830.
39. Yang H, Youm YH, Vandanmagsar B, et al. 2010; Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 185(3): 1836-1845.
40. Yu G, Wu X, Dietrich MA, et al. 2010; Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyses. Cytotherapy 12: 538-546.
41. Zuk PA, Zhu M, Ashjian P, et al. 2002; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12): 4279-4295.
42. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2): 211-228.